LBTD — Lotus Bio-Technology Development Cashflow Statement
0.000.00%
Last trade - 00:00IndustrialsHighly SpeculativeMicro Cap
Annual cashflow statement for Lotus Bio-Technology Development, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2013 March 31st | R2014 March 31st | 2015 March 31st | R2016 March 31st | 2017 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K/A |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.062 | -0.016 | -0.019 | -0.019 | -0.02 |
| Amortisation | |||||
| Non-Cash Items | 0 | — | — | 0 | 0.005 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.01 | 0.004 | 0.003 | 0.02 | -0.004 |
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.072 | -0.012 | -0.016 | 0.002 | -0.018 |
| Capital Expenditures | 0 | — | — | — | — |
| Software Development Costs | |||||
| Cash from Investing Activities | 0 | — | — | — | — |
| Financing Cash Flow Items | -0.028 | 0.008 | 0.017 | 0 | 0.011 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.076 | 0.008 | 0.017 | 0 | 0.018 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.004 | -0.004 | 0.002 | 0.002 | 0 |